[Some aspects of the pathogenetic pharmacotherapy of acute, experimental myocardial ischemia].
D000208:Acute Disease; D000818:Animals; D001205:Ascorbic Acid / Q000037:antagonists & inhibitors; D002395:Catecholamines / Q000037:antagonists & inhibitors; D003097:Collateral Circulation / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006651:Histocytochemistry; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects
D002395:Catecholamines; D006634:Histamine H1 Antagonists; D001205:Ascorbic Acid
Nekotorye aspekty patogeneticheskoĭ farmakoterapii ostroĭ ishemii miokarda v éksperimente